Jazz Pharmaceuticals (JAZZ)
Company | Ticker | Sector | Industry | Quality | PAR |
---|---|---|---|---|
Jazz Pharmaceuticals | JAZZ | Healthcare | Biotechnology | 65 | 15.4% |
Current Price (06/29) | $156.36 | |||
CAPS Rating (Rate this stock on CAPS) | ![]() |
|||
Expected Income Statement | ||||
Current Sales | 3,300.4 | |||
Sales Growth Forecast | 12.5% | |||
Net Profit Margin | 30.2% | |||
Projected Shares Outstanding | 69.92 | |||
EPS - Five year Forecast | $25.64 | |||
Average P/E Ratio | 12.5 | |||
Projected Average Price | $320.53 | |||
Price Appreciation (Annualized) | 15.4% | |||
Annual Dividend Yield | 0.0% | |||
Projected Annual Return | 15.4% | |||
Quality | ||||
Financial Strength | 69 | 17.2 | ||
EPS Stability | 61 | 15.3 | ||
Industry Sales Growth Rate | 15.0% | 10.4 | ||
Industry Net Profit Margin | 30.0% | 12.6 | ||
Calculated Quality Rating | 55.5 | |||
Fool CAPS | ||||
Total Players
286
Outperforms
67
Underperforms
All-Stars (68)
53
Outperforms (78%)
15
Underperforms
|
||||
Fundamental Data Updated: 06/03/2022 |